We are live on ! Find out more
SRTS icon

Sensus Healthcare

54 hedge funds and large institutions have $44.7M invested in Sensus Healthcare in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,520% more call options, than puts

Call options by funds: $2.68M | Put options by funds: $74K

217% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 6

172% more capital invested

Capital invested by funds: $16.4M → $44.7M (+$28.3M)

120% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 10

32% more funds holding

Funds holding: 4154 (+13)

12.82% more ownership

Funds ownership: 13.71%26.53% (+13%)

Holders
54
Holders Change
+13
Holders Change %
+31.71%
% of All Funds
0.85%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
22
Reduced
10
Closed
6
Calls
$2.68M
Puts
$74K
Net Calls
+$2.6M
Net Calls Change
+$2.34M
Name Holding Trade Value Shares
Change
Change in
Stake
HIM
1
Hillsdale Investment Management
Ontario, Canada
$6.07M +$5.48M +599,436 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$6.03M +$1.06M +116,409 +24%
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$3.3M +$1.98M +216,413 +197%
EI
4
EAM Investors
California
$3.27M +$1.12M +122,988 +61%
Renaissance Technologies
5
Renaissance Technologies
New York
$3.16M +$1.37M +150,200 +93%
EGI
6
EAM Global Investors
California
$1.77M +$1.6M +175,257 New
Ameriprise
7
Ameriprise
Minnesota
$1.67M +$35.8K +3,917 +2%
PPA
8
Parametric Portfolio Associates
Washington
$1.46M +$1.32M +144,210 New
Marshall Wace
9
Marshall Wace
United Kingdom
$1.33M -$585K -64,067 -33%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$1.33M +$577K +63,155 +92%
BlackRock
11
BlackRock
New York
$1.25M -$1.38K -151 -0.1%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.23M +$276K +30,212 +33%
EWM
13
Empirical Wealth Management
Washington
$851K
Millennium Management
14
Millennium Management
New York
$838K +$757K +82,852 New
EGM
15
Engineers Gate Manager
New York
$829K +$308K +33,662 +70%
PAIM
16
Punch & Associates Investment Management
Minnesota
$810K +$731K +80,000 New
UBS Group
17
UBS Group
Switzerland
$714K +$616K +67,458 +2,200%
NA
18
Navellier & Associates
Nevada
$551K +$497K +54,401 New
CIC
19
Cornercap Investment Counsel
Georgia
$551K +$498K +54,465 New
Two Sigma Advisers
20
Two Sigma Advisers
New York
$517K +$158K +17,300 +51%
CAM
21
ClariVest Asset Management
California
$469K +$423K +46,300 New
State Street
22
State Street
Massachusetts
$466K +$34.4K +3,765 +9%
CSS
23
Cubist Systematic Strategies
Connecticut
$466K +$64.7K +7,084 +18%
Janney Montgomery Scott
24
Janney Montgomery Scott
Pennsylvania
$456K -$27.4K -3,000 -6%
Goldman Sachs
25
Goldman Sachs
New York
$418K +$198K +21,717 +111%

SRTS Hedge Fund Activity: Q1 2022 in Review

54 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare (SRTS) for Q1 2022, worth a combined $44.7M — up 172% from $16.4M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new SRTS positions and 6 closed out — a net gain of 13 holders — while 22 added to existing stakes and 10 trimmed.

The largest buyer was Hillsdale Investment Management, opening a new position worth an estimated $5.48M. The largest seller was Marshall Wace, cutting an estimated $585K.

  • 54 institutional investors held Sensus Healthcare (SRTS) as of Q1 2022, up from 41 in Q4 2021.
  • Funds reported $44.7M of Sensus Healthcare stock for Q1 2022, up 172% quarter-over-quarter.
  • 19 funds opened new Sensus Healthcare positions in Q1 2022 and 6 closed out, a net change of +13 holders.
  • The largest Sensus Healthcare buyer in Q1 2022 was Hillsdale Investment Management, an estimated $5.48M added.
  • The largest Sensus Healthcare seller in Q1 2022 was Marshall Wace, an estimated $585K sold.

Based on aggregated 13F filings for Q1 2022.